rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    IRIX
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Iridex (NASDAQ: IRIX) Shares Fall 26.96% After Hours: What Investors Should Know
      21h agoBenzingaIRIX
      IRIDEX earnings missed by $0.06, revenue fell short of estimates
      Nov 17Investing.comIRIX
      Iridex CFO Romeo Dizon buys $4,977 in company stock
      Nov 15Investing.comIRIX
      Iridex to Report Third Quarter 2026 Financial Results on November 17, 2026
      Nov 3Yahoo FinanceIRIX
      Iridex study shows two-year glaucoma treatment outcomes
      Oct 12Investing.comIRIX
      Iridex reports 2-year glaucoma study shows sustained IOP reduction
      Oct 12Investing.comIRIX
      Iridex Announces the Publication of Two-Year Independent Study Supporting Benefits of MicroPulse® Technology for Early to Advanced Glaucoma
      Oct 12Yahoo FinanceIRIX
      Iridex Says Glaucoma Therapy Lowers Eye Pressure, Reduces Medication Use
      Oct 12Yahoo FinanceIRIX
      Iridex director Lin Shih-Yao David buys $273,611 in company stock
      Oct 7Investing.comIRIX
      Iridex director David Lin’s entity buys $597,902 in common stock
      Oct 7Investing.comIRIX
      Iridex director Lin Shih-Yao David buys $438,762 in stock
      Oct 7Investing.comIRIX
      Iridex Receives Nasdaq Notice Over Minimum Bid Price

      Detailed price information for Iridex Corp (IRIX-Q) from The Globe and Mail including charting and trades.

      Sep 3The Globe and MailIRIX
      IRIDEX (IRIX) Q2 2026 Earnings Call Transcript

      Motley Fool Press Release.

      Aug 25The Globe and MailIRIX
      IRIDEX Q2 Loss Widens Y/Y as Retina Weakness Weighs, Stock Down 15%

      IRIX's Q2 loss per share widens year over year and revenues decline as Middle East disruptions and reduced sell-through in China weigh on retina sales, offsetting continued growth in the Cyclo G6 product family.

      Aug 25Yahoo FinanceIRIX
      Analysts’ Opinions Are Mixed on These Healthcare Stocks: Iridex (IRIX) and Aurora Cannabis (ACB)

      Tipranks Press Release.

      Aug 21The Globe and MailIRIX

      This is the newest page. Registered accounts read further back.